Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolizing Enzymes.

NCT02983890 is registered in ClinicalTrials.gov with Per Damkier as lead sponsor.

NCT NCT02983890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02983890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolizing Enzymes.
Lead sponsor
Per Damkier
Phase
Phase 1
Overall status
Completed
Start date
October 6, 2016
Completion date
October 1, 2017
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy